Literature DB >> 11877327

Ca(2+) signalling by recombinant human CXCR2 chemokine receptors is potentiated by P2Y nucleotide receptors in HEK cells.

Tim D Werry1, Mark I Christie, Ian A Dainty, Graeme F Wilkinson, Gary B Willars.   

Abstract

1. Human embryonic kidney (HEK)-293 cells expressing recombinant G alpha(i)-coupled, human CXC chemokine receptor 2 (CXCR2) were used to study the elevation of the intracellular [Ca(2+)] ([Ca(2+)](i)) in response to interleukin-8 (IL-8) following pre-stimulation of endogenously expressed P2Y1 or P2Y2 nucleotide receptors. 2. Pre-stimulation of cells with adenosine 5'-triphosphate (ATP) revealed a substantial Ca(2+) signalling component mediated by IL-8 (E(max)=83 +/- 8% of maximal ATP response, pEC(50) of IL-8 response=9.7 +/- 0.1). 3. 1 microM 2-methylthioadenosine 5'-diphosphate (2MeSADP; P2Y1 selective) and 100 microM uridine 5'-triphosphate (UTP; P2Y2 selective) stimulated equivalent maximal increases in [Ca(2+)](i) elevation. However, UTP caused a sustained elevation, whilst following 2MeSADP [Ca(2+)](i) rapidly returned to basal levels. 4. Both UTP and 2MeSADP increased the potency and magnitude of IL-8-mediated [Ca(2+)](i) elevation but the effects of UTP (E(max) of IL-8 response increased to 50 +/- 1% of the maximal response to ATP, pEC(50) increased to 9.8 +/- 0.1) were greater than those of 2MeSADP (E(max) increased to 36 +/- 2%, pEC(50) increased to 8.7 +/- 0.2). 5. 5. The potentiation of IL-8-mediated Ca(2+) signalling by UTP was not dependent upon the time of IL-8 addition following UTP but was dependent on the continued presence of UTP. Potentiated IL-8 Ca(2+) signalling was apparent in the absence of extracellular Ca(2+), demonstrating the release of Ca(2+) from intracellular stores. 6. Activation of P2Y1 and P2Y2 receptors also revealed Ca(2+) signalling by an endogenously expressed, G alpha(s)-coupled beta-adrenoceptor. 7. In conclusion, pre-stimulation of P2Y nucleotide receptors, particularly P2Y2, facilitates Ca(2+) signalling by either recombinant CXCR2 or endogenous beta-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11877327      PMCID: PMC1573230          DOI: 10.1038/sj.bjp.0704566

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  39 in total

1.  Coincident signalling between the Gi/Go-coupled delta-opioid receptor and the Gq-coupled m3 muscarinic receptor at the level of intracellular free calcium in SH-SY5Y cells.

Authors:  A Yeo; D S Samways; C E Fowler; F Gunn-Moore; G Henderson
Journal:  J Neurochem       Date:  2001-03       Impact factor: 5.372

Review 2.  International union of pharmacology. XXII. Nomenclature for chemokine receptors.

Authors:  P M Murphy; M Baggiolini; I F Charo; C A Hébert; R Horuk; K Matsushima; L H Miller; J J Oppenheim; C A Power
Journal:  Pharmacol Rev       Date:  2000-03       Impact factor: 25.468

3.  Preactivation permits subsequent stimulation of phospholipase C by G(i)-coupled receptors.

Authors:  J S Chan; J W Lee; M K Ho; Y H Wong
Journal:  Mol Pharmacol       Date:  2000-04       Impact factor: 4.436

4.  The distribution of receptors for the pro-inflammatory cytokines interleukin (IL)-6 and IL-8 in the developing human fetus.

Authors:  J B Dame; S E Juul
Journal:  Early Hum Dev       Date:  2000-04       Impact factor: 2.079

5.  Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons.

Authors:  C M Coughlan; C M McManus; M Sharron; Z Gao; D Murphy; S Jaffer; W Choe; W Chen; J Hesselgesser; H Gaylord; A Kalyuzhny; V M Lee; B Wolf; R W Doms; D L Kolson
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

6.  Pharmacological characterization of the human P2Y11 receptor.

Authors:  D Communi; B Robaye; J M Boeynaems
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

7.  The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity.

Authors:  C L Addison; T O Daniel; M D Burdick; H Liu; J E Ehlert; Y Y Xue; L Buechi; A Walz; A Richmond; R M Strieter
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

Review 8.  CXC chemokines in angiogenesis.

Authors:  J A Belperio; M P Keane; D A Arenberg; C L Addison; J E Ehlert; M D Burdick; R M Strieter
Journal:  J Leukoc Biol       Date:  2000-07       Impact factor: 4.962

9.  Parathyroid hormone potentiates nucleotide-induced [Ca2+]i release in rat osteoblasts independently of Gq activation or cyclic monophosphate accumulation. A mechanism for localizing systemic responses in bone.

Authors:  K A Buckley; S C Wagstaff; G McKay; A Gaw; R A Hipskind; G Bilbe; J A Gallagher; W B Bowler
Journal:  J Biol Chem       Date:  2000-12-21       Impact factor: 5.157

10.  Activation of mitogen-activated protein kinase by the A(2A)-adenosine receptor via a rap1-dependent and via a p21(ras)-dependent pathway.

Authors:  M G Seidel; M Klinger; M Freissmuth; C Höller
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

View more
  17 in total

Review 1.  Elusive equilibrium: the challenge of interpreting receptor pharmacology using calcium assays.

Authors:  Steven J Charlton; Georges Vauquelin
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

Review 2.  Mechanisms regulating chemokine receptor activity.

Authors:  Laura D Bennett; James M Fox; Nathalie Signoret
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

Review 3.  P2 receptors: intracellular signaling.

Authors:  Laurie Erb; Zhongji Liao; Cheikh I Seye; Gary A Weisman
Journal:  Pflugers Arch       Date:  2006-04-04       Impact factor: 3.657

Review 4.  International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.

Authors:  Maria P Abbracchio; Geoffrey Burnstock; Jean-Marie Boeynaems; Eric A Barnard; José L Boyer; Charles Kennedy; Gillian E Knight; Marta Fumagalli; Christian Gachet; Kenneth A Jacobson; Gary A Weisman
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

Review 5.  Interaction of P2 purinergic receptors with cellular macromolecules.

Authors:  Laszlo Köles; Zoltan Gerevich; João Felipe Oliveira; Zoltan Sandor Zadori; Kerstin Wirkner; Peter Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-19       Impact factor: 3.000

6.  Improvements in live cell analysis of G protein coupled receptors using second generation BD calcium assay kits.

Authors:  Xiao Li; Isabel Llorente; Mike Brasch
Journal:  Curr Chem Genomics       Date:  2008-10-10

7.  Co-incident signalling between mu-opioid and M3 muscarinic receptors at the level of Ca2+ release from intracellular stores: lack of evidence for Ins(1,4,5)P3 receptor sensitization.

Authors:  Damien S K Samways; Wen-hong Li; Stuart J Conway; Andrew B Holmes; Martin D Bootman; Graeme Henderson
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

8.  Full and partial agonists of muscarinic M3 receptors reveal single and oscillatory Ca2+ responses by beta 2-adrenoceptors.

Authors:  Nisha Kurian; Caroline J Hall; Graeme F Wilkinson; Michael Sullivan; Andrew B Tobin; Gary B Willars
Journal:  J Pharmacol Exp Ther       Date:  2009-05-06       Impact factor: 4.030

9.  Signaling and cross-talk by C5a and UDP in macrophages selectively use PLCbeta3 to regulate intracellular free calcium.

Authors:  Tamara I A Roach; Robert A Rebres; Iain D C Fraser; Dianne L Decamp; Keng-Mean Lin; Paul C Sternweis; Mel I Simon; William E Seaman
Journal:  J Biol Chem       Date:  2008-04-14       Impact factor: 5.157

10.  Parathyroid hormone increases the sensitivity of inositol trisphosphate receptors by a mechanism that is independent of cyclic AMP.

Authors:  Stephen C Tovey; Tasmina A Goraya; Colin W Taylor
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.